Marketing Formerly Dangerous Drugs
Two scholars find that the removal of FDA health warnings prompts an increase in drug marketing.
Broadening Access to COVID-19 Drugs
Regulators should expand the types of medical professionals who can prescribe COVID-19 drugs.
The AI Health Care Dilemma
Scholars explore regulatory approaches to artificial intelligence in the health care sector.
Negotiating Prices with Drug Manufacturers
The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States.
How Factory Farming Could Cause the Next COVID-19
The CDC should recommend agricultural reforms to reduce pandemic risks caused by factory farms.
The ADA’s Power to Reduce Overdose Deaths in Prison
Scholars argue that the ADA’s protections could prevent overdose deaths for people in prison.
Toxic Metals in Baby Food Remain Unregulated
Despite delayed government action, manufacturers can do more to reduce toxic metals in baby food.
Telehealth Abortion Care
Scholars consider how the authorization of telehealth can expand access to medication abortion.
Are Food Regulators Stepping up to the Plate?
In this week’s Saturday Seminar, we collect scholarship discussing quality and safety issues within U.S. food regulation.
Hallucinate, Medicate, and Regulate
In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.
Nonprofit Hospital Standards Under Fire
Research shows that nonprofit hospitals may not be fulfilling the obligations of their tax-exempt status
Using Insurance to Regulate Food Safety
Insurance underwriters can help farmers manage the risk of microbial contamination in their fields.